Casp9 Cancer Research Results

Casp9, Caspase-9: Click to Expand ⟱
Source:
Type:
Caspase-9 is the apoptotic initiator protease of the intrinsic or mitochondrial apoptotic pathway, which is activated at multi-protein activation platforms.
Caspases are divided into two groups: the initiator caspases (caspase-2, -8, -9 and -10), which are the first to be activated in response to a signal, and the executioner caspases (caspase-3, -6, and -7) that carry out the demolition phase of apoptosis.
Caspase-9:
Role: Initiator caspase in the intrinsic apoptotic pathway.
Cancers: Frequently studied in leukemia and solid tumors.
Prognosis: Reduced expression is often linked to chemoresistance and poor prognosis.


Scientific Papers found: Click to Expand⟱
3531- Lyco,    Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system
- in-vivo, Nor, NA
*NRF2↑, *HO-1↑, *NQO1↑, *ROS↓, *mtDam↓, *Bcl-2↑, *BAX↓, *Casp9↓, *Casp3↓, *Apoptosis↓, *RenoP↑, *lipid-P↓, *SOD↑, *GPx↑, *Inflam↓, *TNF-α↓, *IL6↓, *IL10↓,
3263- Lyco,    Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening
- in-vitro, Nor, H9c2 - in-vitro, Stroke, NA
*Apoptosis↓, *MMP↑, *Cyt‑c↓, *APAF1↓, *cl‑Casp9↓, *cl‑Casp3↓, *Bcl-2↑, *BAX↓, cardioP↑,
4777- Lyco,    Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells
- in-vitro, GC, AGS
*antiOx↑, tumCV↓, DNAdam↑, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, Bax:Bcl2↑, ROS↓, NF-kB↓, COX2/PTGS2↓, EGFR↓, p38↓,
1715- Lyco,    Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence
- Review, Var, NA
antiOx↑, ROS↑, ChemoSen↑, selectivity↑, eff↓, Casp3↑, Casp7↑, Casp9↑, P53↑, BAX↑, DNAdam↑, mtDam↑, Synergy↑,
8524- MAG,    Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells
- in-vitro, Pca, PC3 - in-vitro, CRC, HCT116
Apoptosis↑, Akt?, BAD↑, Cyt‑c↑, cl‑Casp8↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, NA⇅, selectivity↑, p‑EGFR↓, p‑PI3K↓, p‑Akt↓,
8519- MAG,    Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway
- vitro+vivo, Gall, NA
TumCG?, TumCCA↑, mt-Apoptosis↑, P53↑, P21↑, cycD1/CCND1↓, CDC25↓, CDK2↓, MMP↓, Bax:Bcl2↑, Casp9↑, Casp3↑, cl‑PARP↑,
8492- MAG,    Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway
- in-vivo, AD, NA
*Apoptosis↑, *cl‑Casp9↓, *BAX↓, *Bcl-2↓, *p62↓, *LC3II↑, *Beclin-1/ATG6↑, *AMPK↑, *mTOR↑, *ULK1/ATG1↑,
8511- MAG,    Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo
- vitro+vivo, CRC, HT-29 - in-vitro, Colon, CT26
p‑PKCδ↓, p‑NF-kB↓, TumCI↓, Fas↓, FasL↓, TumCG?, toxicity↓, cl‑Casp8↑, MMP↓, Casp9↑, ChemoSen↑,
8509- MAG,  Rad,    The In Vivo Radiosensitizing Effect of Magnolol on Tumor Growth of Hepatocellular Carcinoma
- in-vivo, HCC, NA
TumVol↓, TumW↓, *ERK↓, *NF-kB↓, Casp3↑, Casp9↑, RadioS↑, *toxicity↓, Ki-67↓, IL1β↓, TNF-α↓,
1314- MAG,    Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells
- in-vitro, Melanoma, A375
TumCP↓, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓, BAX↑,
4514- MAG,    Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
- Review, Var, NA
AntiCan↑, TumCP↓, TumCCA↑, TumMeta↓, angioG↓, NF-kB↓, MAPK↓, PI3K↓, Akt↓, mTOR↓, BioAv↓, *antiOx↑, *Inflam↓, *AntiAg↑, ChemoSen↑, cycD1/CCND1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK2↓, CDK4↓, p27/CDKN1B↑, P21↑, P53↑, PTEN↓, XIAP↓, Mcl-1↓, Casp3↑, Casp9↑, MMP9↑,
4534- MAG,    Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells
- in-vitro, Liver, HepG2 - in-vitro, CRC, COLO205
AntiCan↑, Apoptosis↑, selectivity↑, Ca+2↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,
4527- MAG,    Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway
- in-vitro, ESCC, TE1 - in-vitro, ESCC, Eca109 - vitro+vivo, SCC, KYSE150
TumCP↓, TumCMig↓, MMP2↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, BAX↑, Bcl-2↓, p‑p38↓, TumCG↓,
4519- MAG,    Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
- Review, Var, NA
*antiOx↑, *Inflam↓, *Bacteria↓, *AntiAg↑, *BBB↑, *BioAv↓, BAD↑, Casp3↑, Casp6↑, Casp9↑, JNK↑, Bcl-xL↓, PTEN↑, Akt↓, NF-kB↓, MMP7↓, MMP9↓, uPA↓, Hif1a↓, VEGF↓, FOXO3↓, Ca+2↑, TumCCA↑, ROS↑, Cyt‑c↑,
8572- Matr,    Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling
- in-vitro, Lung, A549 - in-vitro, Lung, H460
Dose?, β-catenin/ZEB1↓, survivin↓, MMP↓, Casp9↑, Casp3↑,
8536- Matr,    Effect of matrine against breast cancer by downregulating the vascular endothelial growth factor via the Wnt/β-catenin pathway
- vitro+vivo, BC, 4T1 - in-vitro, BC, MCF7
tumCV↓, Apoptosis↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, cl‑Casp9↑, cl‑Casp3↑, Cyt‑c↑, angioG↓,
8559- Matr,    Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism
- vitro+vivo, Nor, NA
*Dose↝, *toxicity↑, *Casp3↑, *Casp9↑, *ROS↑, *MMP↓, *ATP↓, *eff↓,
8557- Matr,    Effects of matrine in combination with cisplatin on liver cancer
- in-vivo, Liver, HepG2
ChemoSen?, TumW↓, TumVol↓, survivin↓, XIAP↓, Casp3↑, Casp7↑, Casp9↑,
8555- Matr,    Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
- Review, Var, NA
*AntiTum↑, *Inflam↓, *Analgesic↑, *AntiViral↑, *Imm↑, *PI3K↑, *Akt↑, *mTOR↑, TumAuto↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, E-cadherin↑, Vim↓, MMP2↓, MMP9↓, Snail↓, Slug↓, PTEN↑, TumCP↓, TumCMig↓, TumCI↓, ChemoSen↑, ROS↑, uPA↓, p‑ERK↓, cachexia↓, antiD↑, GSK‐3β↓, LC3B-II↑, p62↓, Apoptosis↑, Casp3↑, Casp8↑, Casp9↑, FOXO1↑, FOXO3↑, FOXO4↑, PARP↑, BIM↑, Bcl-2↓, survivin↓, miR-21↓, *HOTAIR↑, *p‑Akt↑, *p‑STAT3↑, *STAT3↑, *ROS↓, Wnt↓, β-catenin/ZEB1↓, NOTCH1↓, JAG1↓, HES1↓, BioAv↝, toxicity↝,
8753- MeSA,    Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis
- vitro+vivo, GBM, U251 - in-vitro, GBM, U87MG
Apoptosis↑, Casp7↑, Casp9↑, Casp3↑, ROS↑, TumCG↓,
8759- MeSA,    Methylseleninic acid induces apoptosis of human bladder cancer cells through the ROS-mediated mitochondrial pathway
- in-vitro, Bladder, J82 - in-vitro, CRC, T24/HTB-9
tumCV↓, TumCCA↑, Apoptosis↑, ROS↑, MMP↓, eff↓, BAX↑, Bcl-2↓, Cyt‑c↑, Casp9↑, Casp3↑,
3464- MF,    Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology
- Review, Var, NA
AntiTum↑, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↑, Diff↑, angioG↓, TumMeta↓, EPR↑, ChemoSen↑, ROS↑, DNAdam↑, P53↑, Akt↓, MAPK↑, Casp9↑, VEGFR2/KDR/Flk1↓, P-gp/ABCB1↓,
3486- MF,    Pulsed electromagnetic field potentiates etoposide-induced MCF-7 cell death
- in-vitro, BC, MCF-10AT
ChemoSen↑, tumCV↓, cl‑PARP↑, Casp7↑, Casp9↑, survivin↓, BAX↑, DNAdam↑, ROS↑, eff↓,
4353- MF,  Chemo,    Pulsed Electromagnetic Field Enhances Doxorubicin-induced Reduction in the Viability of MCF-7 Breast Cancer Cells
- in-vitro, BC, MCF7
TumCCA↑, Apoptosis↑, ChemoSen↑, TumCCA↑, Casp↝, p‑CDK2↓, cycE/CCNE↓, Fas↑, BAX↑, survivin↓, Mcl-1↓, cl‑PARP↑, cl‑Casp7↑, cl‑Casp8↑, cl‑Casp9↑,
2259- MFrot,  MF,    Method and apparatus for oncomagnetic treatment
- in-vitro, GBM, NA
MMP↓, Bcl-2↓, BAX↑, Bak↑, Cyt‑c↑, Casp3↑, Casp9↑, DNAdam↑, ROS↑, lactateProd↑, Apoptosis↑, MPT↑, *selectivity↑, ChemoSen↑, MMP↓, selectivity↑, TCA?, H2O2↑, eff↑, *antiOx↑, H2O2↑, eff↓, GSH/GSSG↓, *toxicity∅, OS↑,
9156- MG, MIC-1,    Moringin from Moringa Oleifera Seeds Inhibits Growth, Arrests Cell-Cycle, and Induces Apoptosis of SH-SY5Y Human Neuroblastoma Cells through the Modulation of NF-κB and Apoptotic Related Factors
- in-vitro, neuroblastoma, SH-SY5Y
TumCG↓, TumCCA↑, P53↑, P21↑, BAX↑, cl‑Casp3↑, cl‑Casp9↑, NF-kB↓,
9074- MGF,    Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway
- in-vitro, GC, SGC-7901 - in-vitro, GC, BGC-823
TumCP↓, Dose?, Bcl-2↓, Bcl-xL↓, Mcl-1↓, BAX↑, BAD?, cl‑Casp3↑, cl‑Casp9↑, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, toxicity↓,
9087- MGF,    Mangiferin in human disease: Multifaceted mechanisms and applications (Review)
- Review, Var, NA
TumCP↓, TumCI↓, angioG↓, *BioAv↓, *neuroP↑, *Inflam↓, *AntiCan↑, *ROS↓, *BioAv↑, *BioAv↝, *Half-Life↝, *BBB↓, CDK1↑, CycB/CCNB1↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, PI3K↓, Akt↓, mTOR↓, MMP↓, MOMP↑, Apoptosis↑, lipid-P↑, TCA↓, NRF2↑, NQO1↑, ROS↓, RadioS↑,
1782- MLT,    Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
- Review, Var, NA
AntiCan↑, Apoptosis↑, TumCP↓, TumCG↑, TumMeta↑, ChemoSideEff↓, radioP↑, ChemoSen↑, *ROS↓, *SOD↑, *GSH↑, *GPx↑, *Catalase↑, Dose∅, VEGF↓, Synergy↑, Hif1a↓, GLUT1↑, GLUT3↑, CAIX/CA9↑, P21↑, p27/CDKN1B↑, PTEN↑, Warburg↓, PI3K↓, Akt↓, NF-kB↓, cycD1/CCND1↓, CDK4↓, CycB/CCNB1↓, CDK4↓, MAPK↑, IGF-1R↓, STAT3↓, MMP9↓, MMP2↓, MMP13↓, E-cadherin↑, Vim↓, RANKL↓, JNK↑, Bcl-2↓, P53↑, Casp3↑, Casp9↑, BAX↑, DNArepair↑, COX2/PTGS2↓, IL6↓, IL8↓, NO↓, T-Cell↑, NK cell↑, Treg lymp↓, FOXP3↓, CD4+↑, TNF-α↑, Th1 response↑, BioAv↝, RadioS↑, OS↑,
8907- MO,    Phenolic Extraction of Moringa Oleifera Leaves Induces Caspase-Dependent and Caspase-Independent Apoptosis through the Generation of Reactive Oxygen Species and the Activation of Intrinsic Mitochondrial Pathway in Human Melanoma Cells
- in-vitro, Melanoma, A375 - in-vitro, Melanoma, A2058
TumCP↓, selectivity↑, ROS↑, MMP↓, BAX↑, Bcl-2↓, Casp3↑, Casp7↑, Casp9↑, AIF↑,
8897- MOR,    Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis
- vitro+vivo, Pca, DU145 - in-vitro, Pca, PC3
tumCV↓, GATA3↑, ChemoSen↑, Dose↝, miR-155↓, MMP?, Casp3↑, Casp9↑, P21↑, BAD↑, Bcl-xL↓, STAT3↓,
8898- MOR,    Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells
- in-vitro, Cerv, HeLa
TumCP↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, WEE1↑, CDK1↓, CDC25↓, survivin↓, CycB/CCNB1↓, Chk2↓, BAX↑, BAD↑, Cyt‑c↑, APAF1↑, Casp9↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, Casp10↑, PARP↑, PI3K↑, Akt↑, mTOR↑, p70S6↑, Diablo↑, Bcl-2↓, Bcl-xL↓, AMPK↓, IAP1↓, NF-kB↓, ROS↑,
8874- MOR,    The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives
- Review, Var, NA
AntiCan↑, selectivity↑, *ROS↓, *Inflam↓, *p‑Akt↓, *NF-kB↓, ChemoSen↑, chemoPv↑, *toxicity↓, BioAv↑, BioAv↓, MRP1/ABCC1↝, BioAv↑, PCNA↓, hepatoP↑, NF-kB↓, TNF-α↓, IL6↓, PGE2↓, MMP2↓, MMP9↓, Apoptosis↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, ROS↑, MMP↓, BAX↑, Bcl-xL↓, Casp9↑, Casp3↑, EMT↓, Akt↓, Hippo↑,
8863- MOR,    Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect
- in-vitro, Colon, SW48
TumCP↓, Apoptosis↑, ROS↑, MMP↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, BAX↑, Bcl-2↓, ATP↓, GlucoseCon↓, GLUT1↓, Warburg↓, Dose↝, Catalase↓, GSH↓, ADP:ATP↑, AMP↑,
8862- MOR,    The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells
- in-vitro, CRC, HCT116
Fas↑, Casp8↑, Casp9↑, Casp3↑, BID↑, MMP↓, BAX↑, Cyt‑c↑, ROS↑, Bcl-2↓, IAP1↓, Apoptosis↑, Akt↓,
8880- MOR,    Morin, a Natural Flavonoid, Activates the PINK1/Parkin Pathway to Induce Mitophagy, Promote Apoptosis, and Suppress Cancer Stemness in Pancreatic Cancer
- in-vitro, PC, NA
tumCV↓, TumCMig↓, TumCI↓, CSCs↓, N-cadherin↓, Snail↓, Zeb1↓, SOX2↓, Nanog↓, OCT4↓, E-cadherin↑, ALDH↓, mtDam↑, MMP↓, compV↓, mt-ROS↑, PINK1↑, PARK2↑, AMPK↑, LC3A↑, LC3B↑, MFN2↓, MitoP↑, Apoptosis↑, Casp3↑, Casp9↑, Cyt‑c↑,
8879- MOR,  doxoR,    Synergistic Effects of Morin and Doxorubicin Overcome Chemoresistance in Ovarian Cancer: Preclinical Insights From in vitro and in vivo Models
- vitro+vivo, Ovarian, OVCAR-3 - NA, Melanoma, A2780S
Dose↝, ChemoSen↑, cycA1/CCNA1↓, cycD1/CCND1↓, TumVol↓, Apoptosis↑, TumCCA↑, ROS↝, chemoP↑, TumAuto↑, ROS↓, SOD↑, Catalase↑, GSH↑, MDA↓, cardioP↑, mTOR↓, PI3K↓, Akt↓, Bcl-2↓, Casp3↑, Casp9↑, LC3A↑, ATG5↑, Beclin-1/ATG6↑,
8859- MOR,    Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1
- in-vitro, Melanoma, U266 - in-vitro, BC, MCF7 - in-vitro, SCC, SCC4 - in-vitro, BC, MCF-10AT
STAT3↓, Src↓, JAK1↓, JAK2↓, PIAS-3↑, ChemoSen↑, SHP1↑, XIAP↓, cFLIP↓, Mcl-1↓, survivin↓, Bcl-2↓, Bcl-xL↓, IAP2/BIRC3↓, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, selectivity↑,
8780- MSM,    Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells
- in-vitro, CRC, HT-29
Apoptosis↑, TumCCA↑, CSCs↓, Dose↝, cl‑PARP↑, cl‑Casp9↑, MMP↓, SOX2↓, OCT4↓, Nanog↓,
8804- MT/VAE,    Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells
- in-vitro, lymphoma, U937
DNAdam↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, cl‑PKCδ↑, Apoptosis↑,
8803- MT/VAE,    Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis
- in-vitro, Var, NA
Imm↝, Casp9↑, Casp9↑, Casp3↑, TumCD↑, Cyt‑c↑, ChemoSen↑,
8968- mushLions,    Mechanism of Hericium erinaceus (Yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells
- in-vitro, lymphoma, U937
Ingr?, Apoptosis↑, TumCP↓, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓, XIAP↓, IAP1↓, Cyt‑c↑, MMP↓, cl‑PARP↑,
8951- mushLions,    Apoptotic mechanisms of gastric cancer cells induced by isolated erinacine S through epigenetic histone H3 methylation of FasL and TRAIL
- vitro+vivo, GC, NA
Apoptosis↑, ROS↑, selectivity↑, TumCG↓, FasL↑, TRAIL↑, PCNA↓, cycD1/CCND1↓, Casp3↑, Casp9↑, Casp8↑, Bcl-2↓, Bcl-xL↓, TumCCA↑, tumCV↓, TumVol↓, TumW↓,
8953- mushLions,    Fruiting body polysaccharides of Hericium erinaceus induce apoptosis in human colorectal cancer cells via ROS generation mediating caspase-9-dependent signaling pathways
- in-vitro, CRC, HCT116 - in-vitro, CRC, DLD1
Ingr↝, BAX↑, Bcl-2↓, MMP↓, cl‑Casp9↑, cl‑Casp3↑, ROS↑, eff↓, Ingr?,
6492- Nimb,    Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer
- Review, Var, NA
Apoptosis↑, TumCCA↑, TumCP↓, TumCI↓, angioG↓, TumMeta↓, PTEN↑, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, IKKα↓, CXCR2↓, CXCR4↓, Bcl-2↓, COX2/PTGS2↓, MMP9↓, VEGF↓, TIMP2↑, chemoPv↑, ROS↑, DR4↑, P53↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, Mcl-1↓, XIAP↓, survivin↓, FasL↑, FADD↑, EGFR↓, MMPs↓,
6490- Nimb,    Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
- in-vitro, Oral, SCC4
PI3K↓, Akt↓, GSK‐3β↑, MMP↓, Apoptosis↑, Bax:Bcl2↑, Cyt‑c↑, cl‑Casp3↑, cl‑Casp9↑, TumAuto↑, Beclin-1/ATG6↓, p62↑, PI3K↓, chemoPv↑,
4630- OLE,    Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles
- in-vitro, BC, NA
Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Vim↓, Slug↓, E-cadherin↑, CSCs↓, P21↑, survivin↝, OCT4↑, Nanog↑, SOX4↑,
4643- OLE,  HT,    Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
- Review, Var, NA
TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP/DDIT3↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27/CDKN1B↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,
8424- OM,    Origanum majorana Essential Oil Triggers p38 MAPK-Mediated Protective Autophagy, Apoptosis, and Caspase-Dependent Cleavage of P70S6K in Colorectal Cancer Cells
- in-vitro, CRC, HT-29
tumCV?, mTOR↓, P70S6K↓, Casp8↑, Casp9↑, p38↑, MAPK↑,
9049- PatchO,    Inhibitory effects of patchouli alcohol on hepatocellular carcinoma growth through accumulation of oxidative stress and inactivation of androgen receptor signaling
- vitro+vivo, HCC, HepG2 - in-vivo, Liver, HUH7
ROS?, MMP↓, DNAdam↑, TumCCA↑, Apoptosis↑, P53↑, P21↑, Fas↑, FasL↑, Casp8↑, BAX↑, Casp9↑, ChemoSen↑, AR↓, TumCP↓, selectivity↑, eff↓, Snail↓, Twist↓, ICAM-1↓, VCAM-1↓, MMP9↓, EMT↓, toxicity↓, chemoP↑,

Showing Research Papers: 401 to 450 of 563
Prev Page 9 of 12 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 563

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA⇅, 1,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 2,   antiOx↑, 7,   antiOx⇅, 1,   ARE↓, 1,   Catalase↓, 14,   Catalase↑, 7,   Copper↑, 1,   Fenton↑, 2,   frataxin↑, 1,   GCLC↑, 1,   GCLM↓, 1,   GCLM↑, 1,   GPx↓, 5,   GPx↑, 3,   GPx4↓, 5,   GSH↓, 40,   GSH↑, 9,   GSH/GSSG↓, 4,   GSR↑, 3,   GSS↑, 1,   GSSG↓, 1,   GSSG↑, 1,   GSTs↓, 1,   GSTs↑, 3,   H2O2↓, 1,   H2O2↑, 8,   i-H2O2↑, 1,   HO-1↓, 7,   HO-1↑, 13,   HO-1↝, 1,   HO-2↓, 1,   Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 8,   lipid-P↑, 13,   lipid-P↝, 1,   MDA↓, 5,   MDA↑, 5,   MPO↓, 2,   NADPH/NADP+↓, 1,   NOX4↑, 1,   NQO1↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2↓, 17,   NRF2↑, 23,   p‑NRF2↓, 1,   p‑NRF2↑, 1,   Prx↓, 1,   Prx4↑, 1,   PrxII↓, 1,   ROS?, 4,   ROS↓, 26,   ROS↑, 268,   ROS⇅, 10,   ROS↝, 2,   ROS∅, 1,   i-ROS↓, 1,   i-ROS↑, 5,   mt-ROS↑, 7,   SAM-e↝, 1,   SOD?, 1,   SOD↓, 15,   SOD↑, 8,   SOD2↓, 3,   SOD2↑, 2,   TBARS↑, 2,   Thiols↓, 1,   Trx↓, 1,   Trx1↑, 1,   ox-Trx1↑, 1,   TrxR↓, 6,   TrxR1↓, 3,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   FTL↑, 1,   IronCh↑, 3,   NCOA4↑, 1,   STEAP3↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 2,   BCR↓, 1,   CDC2↓, 8,   CDC25↓, 18,   CDC25↑, 1,   p‑CDC25↑, 1,   compI↓, 2,   compIII↓, 1,   compIV↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 2,   ETC↝, 1,   Insulin↓, 2,   MCU↓, 1,   MFN2↓, 1,   MFN2↑, 1,   mitResp↓, 2,   MKK7↓, 1,   mtDam↑, 32,   OCR↓, 3,   OXPHOS↓, 1,   mt-OXPHOS↓, 1,   PDH↓, 1,   PINK1↑, 2,   SDH↓, 2,   SIRT3↓, 2,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 6,   5LO↓, 2,   p‑ACC↑, 1,   ACLY↓, 2,   ACSL4↑, 1,   ACSL5↑, 2,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALDOA↓, 1,   AMP↑, 1,   AMPK↓, 1,   AMPK↑, 19,   AMPK↝, 1,   p‑AMPK↑, 2,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 14,   ATP↝, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   ECAR↝, 1,   ENO1↓, 2,   FASN↓, 2,   FASN↑, 2,   FBPase↑, 1,   GLS↓, 1,   glucoNG↑, 1,   glucose↓, 1,   GlucoseCon↓, 12,   GlutMet↓, 1,   Glycolysis↓, 24,   GSK‐3β↓, 10,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 5,   p‑GSK‐3β↑, 1,   Histones↑, 1,   HK1↓, 1,   HK2↓, 11,   lactateProd↓, 10,   lactateProd↑, 1,   LDHA↓, 6,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 2,   NADPH↑, 2,   O-Glc↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 6,   PFK↓, 1,   PFK1↓, 2,   PFK2?, 1,   PFK2↓, 2,   PFKP↓, 1,   PGK1↓, 1,   PKM2↓, 4,   PKM2∅, 1,   PLA2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 1,   p‑S6↓, 1,   SAT1↑, 1,   SIRT1↓, 5,   SIRT1↑, 2,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA?, 1,   TCA↓, 3,   TCA↑, 1,   TS↓, 3,   Warburg↓, 3,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1,   AIF↑, 23,   APAF1↑, 19,   Apoptosis↓, 9,   Apoptosis↑, 293,   mt-Apoptosis↑, 4,   ASK1↑, 2,   BAD?, 1,   BAD↓, 4,   BAD↑, 21,   p‑BAD↓, 1,   Bak↓, 1,   Bak↑, 16,   BAX?, 1,   BAX↓, 2,   BAX↑, 235,   BAX⇅, 1,   BAX↝, 1,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 54,   Bcl-2↓, 232,   Bcl-2↑, 6,   Bcl-2↝, 1,   Bcl-2∅, 1,   cl‑Bcl-2↓, 1,   Bcl-xL↓, 56,   Bcl-xL↑, 2,   BID↓, 2,   BID↑, 17,   p‑BID↓, 1,   cl‑BID↑, 3,   BIM↑, 5,   BNIP3↑, 2,   BNIP3↝, 1,   BOK↑, 2,   Casp↑, 13,   Casp↝, 1,   Casp10↓, 1,   Casp10↑, 3,   Casp12?, 1,   Casp12↑, 10,   Casp12↝, 1,   cl‑Casp12↑, 1,   Casp2↑, 5,   Casp3?, 1,   Casp3↓, 7,   Casp3↑, 380,   Casp3↝, 1,   Casp3∅, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 66,   cl‑Casp3⇅, 1,   proCasp3↓, 3,   proCasp3↑, 4,   pro‑Casp3↑, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 4,   Casp7?, 1,   Casp7↑, 41,   cl‑Casp7↑, 8,   Casp8↓, 3,   Casp8↑, 126,   Casp8↝, 1,   Casp8∅, 2,   cl‑Casp8↑, 18,   proCasp8↓, 2,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9?, 2,   Casp9↓, 4,   Casp9↑, 441,   Casp9↝, 1,   Casp9∅, 1,   p‑Casp9↑, 2,   cl‑Casp9↓, 2,   cl‑Casp9↑, 70,   proCasp9↓, 4,   proCasp9↑, 5,   pro‑Casp9↑, 1,   CellShr↑, 1,   cFLIP↓, 11,   Cyt‑c↓, 3,   Cyt‑c↑, 192,   Cyt‑c↝, 1,   Cyt‑c?, 1,   Diablo↑, 10,   DR5↑, 37,   Endon↑, 1,   FADD↑, 14,   Fas↓, 2,   Fas↑, 32,   FasL↓, 1,   FasL↑, 23,   Ferroptosis↑, 5,   cl‑GSDME↑, 1,   HEY1↓, 1,   IAP1↓, 15,   IAP2/BIRC3↓, 5,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 16,   Mcl-1↓, 41,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 11,   MDM2↑, 2,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 8,   NAIP↓, 2,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 7,   p38↓, 6,   p38↑, 30,   p‑p38↓, 4,   p‑p38↑, 6,   PUMA↑, 6,   PUMA↝, 1,   Pyro↑, 1,   RIP3↑, 3,   p‑RIP3↑, 1,   survivin↓, 66,   survivin↝, 1,   TNFR 1↑, 2,   TRAIL↑, 9,   TRAILR↑, 2,   TumCD↓, 1,   TumCD↑, 22,   XIAP↓, 36,   XIAP↑, 1,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt?, 1,   Akt↓, 122,   Akt↑, 8,   p‑Akt↓, 45,   AKT1↓, 6,   Akt2↓, 2,   AMPKα↑, 1,   BRAF↝, 1,   CaMKII ↓, 2,   CK2↓, 4,   cMET↓, 3,   p‑cMET↑, 1,   CREB2↓, 1,   cSrc↓, 3,   EF-1α↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   ERK↓, 44,   ERK↑, 11,   p‑ERK↓, 17,   p‑ERK↑, 4,   p‑ERK⇅, 1,   e-ERK↑, 1,   FGFR1↓, 3,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 14,   Hippo↑, 1,   HRAS↓, 2,   IGF-1R↓, 8,   IKKα↓, 5,   IKKα↑, 1,   p‑IKKα↓, 1,   IκB↑, 1,   p‑IκB↓, 3,   JAK↓, 3,   JAK1↓, 4,   JAK1↑, 1,   JAK2↓, 9,   p‑JAK2↓, 2,   JNK↓, 6,   JNK↑, 34,   p‑JNK↓, 5,   p‑JNK↑, 4,   cl‑JNK↑, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 34,   MAPK↑, 23,   MAPK↝, 2,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 6,   p‑MEK↓, 3,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR↓, 59,   mTOR↑, 1,   mTOR↝, 2,   p‑mTOR↓, 16,   mTORC2↓, 3,   NRAS↓, 1,   p70S6↓, 2,   p70S6↑, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   P90RSK↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PI3K↓, 88,   PI3K↑, 2,   p‑PI3K↓, 8,   PI3K/Akt↓, 6,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↝, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 2,   PKCδ↓, 8,   p‑PKCδ↓, 1,   cl‑PKCδ↑, 1,   PTEN↓, 2,   PTEN↑, 31,   PTEN↝, 1,   Raf↓, 8,   c-Raf↓, 1,   RAS↓, 8,   RAS↑, 1,   RIP1↑, 1,   S6K↓, 1,   p‑S6K↓, 1,   SHP1↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 5,   Src↓, 3,   c-Src↓, 1,   STAT↓, 2,   STAT3↓, 54,   STAT3↑, 2,   p‑STAT3↓, 15,   p‑STAT3↑, 2,   STAT5↓, 2,   STAT6↓, 1,   TK1↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 2,   ATF4↑, 12,   ATF4↝, 1,   ATFs↑, 1,   ChrMod↝, 1,   cJun↓, 5,   cJun↑, 4,   p‑cJun↑, 2,   cMyc↓, 33,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMTs↓, 5,   EZH2↓, 2,   FOXM1↓, 1,   FOXO↑, 2,   FOXO1↑, 4,   FOXO3↓, 3,   FOXO3↑, 6,   FOXO4↑, 1,   GATA3↑, 1,   H3↑, 2,   ac‑H3↑, 1,   H4↑, 2,   ac‑H4↑, 1,   HATs↓, 6,   HATs↑, 1,   HDAC↓, 16,   HDAC1↓, 4,   HDAC10↑, 1,   HDAC2↓, 2,   HDAC3↓, 4,   HDAC8↓, 2,   HES1↓, 1,   HMTs↓, 1,   miR-106b↓, 1,   miR-133a-3p↑, 1,   miR-155↓, 3,   miR-17↓, 1,   miR-195↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-221↓, 1,   miR-25-5p↓, 1,   miR-25-5p↑, 1,   miR-27a-3p↑, 1,   miR-339-5p↝, 1,   miR-34a↓, 2,   miR-34a↑, 2,   Myc↓, 5,   MYCN↓, 1,   n-MYC↓, 1,   OCT4↓, 9,   OCT4↑, 1,   other↓, 4,   other↑, 6,   other↝, 10,   PhotoS↑, 2,   SALL4↓, 1,   SETBP1↓, 1,   sonoS↑, 1,   SOX2↓, 7,   SOX4↓, 1,   SOX4↑, 2,   SUV39H↓, 2,   TCF-4↓, 2,   TET3↑, 1,   tumCV?, 1,   tumCV↓, 102,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 5,   cl‑ATF6↑, 1,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 30,   cl‑CHOP/DDIT3↑, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 9,   p‑eIF2α↓, 1,   p‑eIF2α↑, 2,   ER Stress↓, 2,   ER Stress↑, 54,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 21,   GRP94↑, 4,   HSF1↓, 1,   HSP27↓, 7,   HSP27↝, 1,   HSP70/HSPA5↓, 4,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 11,   HSP90↑, 1,   HSPs↓, 1,   IRE1↑, 6,   PDI↑, 1,   PERK↑, 10,   p‑PERK↑, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 8,   XBP-1↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 9,   ATG5↝, 1,   ATG7↑, 2,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 21,   Beclin-1/ATG6↝, 1,   CTSB↓, 2,   CTSD↓, 2,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3A↑, 3,   LC3B↑, 2,   LC3B-II↑, 5,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 7,   LC3s↑, 2,   MitoP↑, 2,   p62↓, 5,   p62↑, 3,   PARK2↑, 2,   SESN2↑, 1,   TumAuto↑, 43,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 3,   p‑ATM↑, 2,   ATR↑, 1,   p‑BRCA1↑, 1,   DFF45↓, 2,   DFF45↑, 2,   DNA-PK↑, 2,   DNAdam↓, 2,   DNAdam↑, 84,   DNArepair↓, 2,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC4/XPF↓, 1,   hTERT/TERT↓, 14,   Ku70/XRCC6↓, 1,   MGMT↓, 2,   p16↑, 3,   P53?, 1,   P53↓, 3,   P53↑, 123,   P53∅, 1,   p‑P53↓, 1,   p‑P53↑, 5,   p53 Wildtype↓, 1,   PARP↓, 4,   PARP↑, 41,   PARP↝, 1,   p‑PARP↑, 1,   cl‑PARP↓, 3,   cl‑PARP↑, 130,   cl‑PARP∅, 1,   PARP1↑, 2,   cl‑PARP1↑, 3,   PCNA↓, 29,   RAD51↓, 1,   SIRT6↑, 1,   Telomerase↓, 15,   TOP1↓, 2,   TOP2↓, 4,   TP53↑, 1,   UHRF1↓, 1,   γH2AX↑, 11,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 20,   CDK1↑, 4,   p‑CDK1↑, 1,   CDK2↓, 38,   CDK2↑, 4,   p‑CDK2↓, 1,   CDK4↓, 46,   CDK4↑, 3,   p‑CDK4↓, 1,   CDK6↓, 19,   CDK6↑, 2,   CDK8↓, 1,   CHK1↓, 2,   CHK1↑, 1,   p‑CHK1↑, 1,   Chk2↓, 2,   Chk2↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   cycA1/CCNA1↓, 14,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 36,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 81,   cycD1/CCND1↑, 3,   p‑cycD1/CCND1↓, 1,   CycD3↓, 4,   cycE/CCNE↓, 25,   cycE/CCNE↑, 1,   cycE1↓, 1,   E2Fs↓, 3,   Ki-67↓, 16,   mitA↑, 2,   p19↑, 1,   P21?, 1,   P21↓, 4,   P21↑, 84,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 33,   pRB↑, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 4,   Securin↓, 1,   TumCCA?, 1,   TumCCA↓, 10,   TumCCA↑, 202,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   ALDH↓, 3,   ALDH1A1↓, 2,   BMP7/OP1↓, 1,   BMPs↑, 1,   CD133↓, 7,   CD24↓, 2,   CD34↓, 1,   CEBPA↑, 1,   cFos↓, 5,   cMYB↓, 1,   CSCs↓, 28,   Diff↓, 1,   Diff↑, 3,   FGF↓, 4,   Gli↓, 1,   Gli1↓, 4,   HH↓, 3,   IGF-1↓, 8,   IGF-2↓, 1,   IGFBP3↑, 3,   JAG1↓, 1,   Jun↓, 1,   p‑Jun↑, 1,   Ki-67↓, 16,   Let-7↑, 3,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 7,   Nanog↑, 1,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 11,   NOTCH1↓, 10,   NOTCH1↑, 1,   NOTCH3↓, 2,   OGFr↑, 2,   PTCH1↓, 1,   SCF↓, 1,   Shh↓, 5,   Smo↓, 3,   STAT1↓, 2,   TAZ↓, 1,   TumCG?, 2,   TumCG↓, 78,   TumCG↑, 3,   TumCP↓, 133,   TumCP↑, 3,   tyrosinase↓, 1,   URGCP/URG4↓, 1,   Wnt?, 1,   Wnt↓, 26,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 11,   AP-1↑, 1,   BACH1↓, 1,   Ca+2↓, 6,   Ca+2↑, 45,   Ca+2↝, 6,   i-Ca+2↑, 4,   mt-Ca+2↑, 1,   CAFs/TAFs↓, 1,   Cal1↑, 2,   cal2↑, 5,   CCN2/CTGF↓, 1,   Cdc42↑, 1,   COL1↓, 2,   COL3A1↓, 1,   DLC1↑, 3,   E-cadherin↓, 8,   E-cadherin↑, 41,   EM↑, 1,   EMT↓, 53,   EMT↑, 2,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 16,   p‑FAK↓, 2,   Fibronectin↓, 1,   FOSB↑, 1,   GLI2↓, 1,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KRAS↓, 1,   LAMs↓, 1,   LEF1↓, 1,   MALAT1↓, 1,   MMP1↓, 5,   MMP13↓, 3,   MMP2↓, 81,   MMP3↓, 5,   MMP7↓, 9,   MMP9↓, 94,   MMP9↑, 1,   MMPs↓, 27,   MUC4↓, 1,   N-cadherin↓, 30,   p‑p44↓, 1,   PAI-1/SERPINE1↑, 1,   PDGF↓, 4,   proline↓, 1,   Rac1↓, 1,   Rho↓, 2,   ROCK1↓, 2,   Slug?, 1,   Slug↓, 11,   Smad1↓, 1,   SMAD2↓, 1,   p‑SMAD2↓, 1,   SMAD3↓, 3,   SMAD3↑, 1,   p‑SMAD3↓, 1,   SMAD4↓, 1,   p‑SMAD4↓, 2,   Snail?, 1,   Snail↓, 26,   TET1↓, 1,   TET1↑, 4,   TGF-β↓, 16,   TGF-β↑, 3,   TIMP1↓, 3,   TIMP1↑, 9,   TIMP2↓, 3,   TIMP2↑, 12,   TIMP3↑, 1,   TRIB3↑, 1,   TSP-1↑, 3,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 72,   TumCI↑, 1,   TumCMig↓, 57,   TumMeta↓, 48,   TumMeta↑, 4,   TumPF↓, 2,   Twist↓, 17,   uPA↓, 22,   uPAR↓, 1,   Vim↓, 32,   Zeb1↓, 11,   ZEB2↓, 3,   α-tubulin↓, 1,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 35,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 74,   angioG↑, 1,   CD31/PECAM-1↓, 4,   Endoglin↑, 3,   HIF-1↓, 4,   Hif1a↓, 48,   Hif1a↑, 1,   NO↓, 3,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 16,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   BBB∅, 2,   CLDN2↓, 1,   CLDN2↑, 1,   CX43/GJA1↓, 1,   EPR↑, 3,   GLUT1↓, 13,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 201,   MMP↑, 1,   MPT↑, 8,   NHE1↓, 1,   TRPM7↓, 1,   TRPV1↑, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↓, 1,   CD4+↑, 2,   CD44↓, 12,   CD8+↑, 1,   cDC2↓, 2,   p‑cDC2↑, 1,   COX1↓, 1,   COX2/PTGS2↓, 71,   CXCL1↓, 2,   CXCL12↓, 1,   CXCR2↓, 1,   CXCR4↓, 13,   CXCR4↑, 1,   DR4↑, 8,   DR4∅, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 2,   ICAM-1↓, 4,   IFN-γ↓, 3,   IFN-γ↑, 2,   Igs↓, 1,   IL1↓, 4,   IL10↓, 3,   IL12↓, 2,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 14,   IL2↓, 2,   IL2↑, 2,   IL4↓, 1,   IL6↓, 34,   IL8↓, 6,   Imm↑, 9,   Imm↝, 2,   Inflam↓, 29,   pol-M1↑, 1,   MCP1/CCL2↓, 4,   MCT1↓, 1,   NAF1↓, 1,   NF-kB↓, 122,   NF-kB↑, 4,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 3,   NLRP3↑, 1,   p50↓, 2,   p65↓, 7,   PD-1↓, 1,   PD-L1↓, 3,   PGE2↓, 19,   PSA↓, 7,   RAGE↓, 2,   SOCS-3↓, 1,   T-Cell↑, 2,   T-Cell↝, 1,   Th1 response↑, 2,   Th17↑, 1,   TLR4↓, 3,   TNF-α↓, 30,   TNF-α↑, 5,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   IM↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AR↓, 11,   ER-α36↓, 1,   ER(estro)↓, 1,   PPARα↓, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 3,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   AKR1B10↓, 1,   BioAv↓, 31,   BioAv↑, 36,   BioAv↝, 5,   BioEnh↑, 4,   ChemoSen?, 2,   ChemoSen↓, 3,   ChemoSen↑, 114,   ChemoSen↝, 1,   CompStab↑, 3,   CompStab↝, 2,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1B1↑, 1,   CYP3A4↓, 2,   DDS↑, 1,   Dose?, 5,   Dose↓, 4,   Dose↑, 9,   Dose⇅, 1,   Dose↝, 46,   Dose∅, 7,   eff↓, 77,   eff↑, 69,   eff↝, 8,   eff∅, 1,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 10,   MDR1↓, 4,   MRP1/ABCC1↓, 2,   MRP1/ABCC1↝, 1,   P-gp/ABCB1↓, 13,   P450↓, 4,   RadioS↑, 37,   selectivity?, 1,   selectivity↓, 2,   selectivity↑, 92,   Synergy?, 1,   Synergy↑, 76,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALP↝, 1,   AR↓, 11,   AST↓, 2,   AST↑, 1,   AST↝, 1,   BRAF↝, 1,   p‑BRCA1↑, 1,   CEA↓, 1,   CRP↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 14,   hTERT/TERT↓, 14,   IL6↓, 34,   KRAS↓, 1,   LDH↓, 5,   LDH↑, 5,   LDH↝, 2,   Myc↓, 5,   PD-L1↓, 3,   PSA↓, 7,   RAGE↓, 2,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 46,   antiD↑, 1,   antiNeop↑, 1,   AntiTum↑, 24,   cachexia↓, 2,   cardioP↑, 5,   CardioT↑, 1,   chemoP↑, 24,   chemoPv↑, 18,   chemoPv⇅, 1,   ChemoSideEff↓, 5,   cognitive?, 1,   hepatoP↓, 1,   hepatoP↑, 7,   neuroP↑, 2,   NP/CIPN↓, 1,   OS↑, 8,   Pain↓, 2,   PFS↓, 1,   Pin1↓, 2,   QoL↑, 4,   QoL∅, 1,   radioP↑, 6,   RenoP↑, 9,   Risk↓, 10,   Strength↑, 1,   toxicity↓, 12,   toxicity↑, 4,   toxicity↝, 4,   toxicity∅, 1,   TumNum↓, 2,   TumVol↓, 26,   TumVol↑, 1,   TumW↓, 15,   Weight↑, 2,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 1,   Bacteria↓, 2,   GutMicro↑, 2,   GutMicro↝, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 7,  
Total Targets: 1035

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 5,   antiOx↑, 80,   ARE↑, 1,   Catalase↓, 1,   Catalase↑, 39,   Fenton↓, 1,   GPx↑, 31,   GSH↑, 39,   GSR↓, 1,   GSR↑, 4,   GSTs↓, 2,   GSTs↑, 11,   H2O2↓, 2,   HDL↑, 2,   HO-1↓, 2,   HO-1↑, 16,   Keap1↓, 2,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 29,   MDA↓, 29,   MPO↓, 4,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 3,   NRF2↓, 1,   NRF2↑, 36,   Prx↑, 1,   RNS↓, 4,   ROS↓, 96,   ROS↑, 4,   ROS⇅, 1,   ROS∅, 1,   mt-ROS?, 1,   SOD↓, 2,   SOD↑, 47,   SOD1↑, 1,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 3,   Trx↑, 1,   uricA↓, 1,   VitC↑, 1,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 2,   IronCh↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

DRP1/DNM1L↓, 1,   FIS1↓, 1,   Insulin↑, 1,   MFN2↑, 1,   mitResp↑, 1,   mtDam↓, 2,   PGC-1α↑, 2,   PGC-1α↝, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 1,   adiP↑, 1,   ALAT↓, 12,   AMPK↓, 1,   AMPK↑, 5,   ATP↓, 2,   ATP↑, 7,   cAMP↑, 2,   DGAT1↓, 1,   FASN↓, 1,   glucose↓, 3,   glucose↝, 1,   GlucoseCon↑, 1,   GSK‐3β↓, 5,   H2S↑, 2,   HMG-CoA↓, 1,   LDHA↑, 1,   LDL↓, 3,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 3,   NADPH↑, 2,   PLA2↓, 1,   SIRT1↑, 7,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   APAF1↓, 2,   Apoptosis↓, 15,   Apoptosis↑, 1,   Apoptosis∅, 1,   ASK1↓, 1,   BAX↓, 18,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 3,   Bax:Bcl2↝, 1,   Bcl-2↓, 3,   Bcl-2↑, 12,   Bcl-xL↑, 1,   Casp↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 35,   Casp3↑, 3,   Casp3∅, 1,   cl‑Casp3↓, 3,   cl‑Casp3↑, 1,   Casp6↓, 1,   Casp8↓, 3,   Casp8↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 29,   Casp9↑, 4,   Casp9∅, 1,   cl‑Casp9↓, 4,   cl‑Casp9↑, 1,   Cyt‑c↓, 11,   Cyt‑c∅, 1,   Fas↓, 2,   Fas↑, 2,   FasL↓, 1,   GSDMD↓, 1,   iNOS↓, 17,   iNOS↑, 1,   MLKL↓, 1,   necrosis↓, 1,   p38↓, 2,   p‑p38↓, 1,   Pyro↓, 1,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 6,   p‑Akt↓, 1,   p‑Akt↑, 1,   Akt2↓, 1,   CaMKII ↓, 1,   CREB↑, 2,   ERK↓, 5,   ERK↑, 3,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IKKα↓, 1,   IKKα↑, 1,   IκB?, 1,   JAK↓, 1,   JAK2↑, 1,   JNK↓, 5,   p‑JNK↓, 2,   MAPK↓, 8,   mTOR↓, 1,   mTOR↑, 4,   p‑mTOR↓, 1,   PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 5,   PI3K↑, 5,   PKCδ↓, 1,   PKCδ↑, 1,   RIP1↓, 1,   STAT↓, 1,   STAT3↓, 2,   STAT3↑, 3,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   ATF4↓, 1,   cJun↓, 1,   p‑cMyc↑, 1,   HDAC↓, 2,   HDAC2↓, 1,   HDAC3↓, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 5,   other↝, 5,   RUNX2↑, 1,   tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 1,   CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   GRP78/BiP↑, 2,   GRP94↑, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,   HSPs↑, 1,   IRE1↓, 1,   PERK↓, 1,   UPR↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 4,   Beclin-1/ATG6↑, 2,   LC3II↓, 1,   LC3II↑, 2,   p62↓, 1,   p62↑, 2,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 5,   p16↓, 1,   P53↓, 5,   P53↑, 2,   PARP∅, 1,   cl‑PARP↓, 1,   cl‑PARP↑, 2,   PARP1↓, 1,   p‑γH2AX↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   cycA1/CCNA1↓, 1,   cycE/CCNE↑, 1,   GADD34↓, 1,   Ki-67↓, 1,   P21↓, 3,   P21↑, 2,   TumCCA↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   Diff↝, 1,   Ki-67↓, 1,   neuroG↑, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 1,   Ca+2↓, 1,   Ca+2↑, 1,   COL1↓, 2,   COL1↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   MMP9↓, 1,   p‑Rac1↓, 1,   Rho↓, 1,   ROCK1↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↑, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 1,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   Vim↓, 1,   Zeb1↓, 1,   α-SMA↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   eNOS↑, 1,   Hif1a↓, 4,   Hif1a↑, 1,   NO↓, 11,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 12,   GastroP↑, 3,   GLUT2↑, 1,   GLUT4↑, 1,   IBI↑, 1,   MMP↓, 3,   MMP↑, 10,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPC1↓, 1,   ZO-1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

AIF1/Iba-1↓, 1,   CD19↑, 1,   CD25+↑, 1,   CD4+↑, 3,   CD40↓, 1,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 26,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 2,   IL1↓, 1,   IL10↓, 7,   IL10↑, 4,   IL17↓, 2,   IL18↓, 2,   IL1β↓, 25,   IL2↓, 3,   IL33↓, 1,   IL4↓, 2,   IL4↑, 1,   IL5↓, 1,   IL6↓, 34,   IL6↑, 1,   IL8↓, 4,   Imm↓, 1,   Imm↑, 5,   INF-γ↓, 2,   Inflam↓, 92,   Inflam↑, 1,   IP-10/CXCL-10↓, 1,   LPS↓, 1,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MyD88↓, 1,   NeuroI↓, 2,   NF-kB↓, 32,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 3,   PGE2↓, 14,   RANTES↓, 1,   TLR4↓, 6,   TNF-α↓, 46,   Treg lymp↝, 1,   TRIF↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 3,   Ach↑, 1,   AChE↓, 12,   BChE↓, 4,   BDNF↓, 1,   BDNF↑, 9,   ChAT↑, 2,   DA↑, 1,   MAOA↓, 2,   NGF↑, 2,   PSD95↑, 1,   SNAP25↑, 1,   TPH1↓, 1,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   Aβ↓, 13,   Aβ42↓, 3,   BACE/β-secretase↓, 6,   IDE↑, 1,   tau↓, 3,   p‑tau↓, 2,   XO↝, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

BNP↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 5,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 28,   BioAv↑, 29,   BioAv⇅, 1,   BioAv↝, 13,   BioEnh↑, 2,   CYP2D6↓, 1,   CYP2E1↓, 2,   Dose↓, 1,   Dose↑, 1,   Dose⇅, 1,   Dose↝, 8,   eff↓, 2,   eff↑, 9,   eff↝, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 2,   Half-Life↝, 9,   P-gp/ABCB1↓, 2,   P450↓, 2,   P450↝, 1,   selectivity↑, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 12,   ALB↝, 1,   ALP↓, 5,   AST↓, 11,   BG↓, 1,   BloodF↑, 2,   BP↓, 5,   BUN?, 1,   BUN↓, 2,   CEA↓, 1,   creat↓, 8,   CRP↓, 3,   hs-CRP↓, 1,   IL6↓, 34,   IL6↑, 1,   LDH↓, 6,   NOS2↓, 1,   SpO2↑, 1,   Urea↓, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 1,   antiAll↑, 14,   AntiArt↑, 4,   AntiCan↑, 15,   antiCG↑, 1,   AntiDiabetic↑, 20,   antiNeop↑, 1,   antiPs↑, 3,   AntiTum↓, 2,   AntiTum↑, 5,   cardioP?, 1,   cardioP↑, 33,   chemoP↑, 7,   chemoPv↑, 1,   cognitive↑, 16,   diuretic↑, 3,   hepatoP↑, 30,   Learn↑, 1,   memory↑, 12,   motorD↑, 4,   Mucositis↓, 2,   neuroP↓, 1,   neuroP↑, 53,   Obesity↓, 4,   OS↑, 1,   Pain↓, 2,   radioP↑, 3,   RenoP↑, 8,   Stroke↓, 4,   toxicity?, 1,   toxicity↓, 36,   toxicity↑, 4,   toxicity↝, 7,   toxicity∅, 8,   Weight↑, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 14,   AntiFungal↓, 1,   AntiFungal↑, 3,   AntiP↑, 2,   AntiViral↑, 8,   Bacteria↓, 15,   Diar↓, 2,   GutMicro↑, 10,   Inf↓, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 4,  
Total Targets: 431

Scientific Paper Hit Count for: Casp9, Caspase-9
21 Quercetin
18 Silver-NanoParticles
18 Baicalein
17 Luteolin
16 Curcumin
16 Thymoquinone
15 Emodin
14 Fisetin
13 Kaempferol
12 Sulforaphane (mainly Broccoli)
11 Apigenin (mainly Parsley)
11 Magnolol
9 Allicin (mainly Garlic)
9 Berberine
9 Betulinic acid
9 Chrysin
9 Morin
8 Cisplatin
8 Honokiol
8 Silymarin (Milk Thistle) silibinin
7 Artemisinin
7 Alpha-Lipoic-Acid
7 EGCG (Epigallocatechin Gallate)
7 Gambogic Acid
6 Allyl isothiocyanate
6 Phenethyl isothiocyanate
6 Citric Acid
6 D-limonene
6 Eugenol
6 Garcinol
6 Graviola
5 Benzyl isothiocyanate
5 Ginkgetin
5 Ivermectin
5 Matrine
5 Shikonin
4 Cynara scolymus/Globe Artichoke/Artichoke Extract
4 Ashwagandha(Withaferin A)
4 Bromelain
4 Boron
4 Capsaicin
4 Carvacrol
4 chaetocin
4 Photodynamic Therapy
4 Radiotherapy/Radiation
4 Formononetin
4 Fucoidan
4 Juglone
4 Licochalcone A
4 Lycopene
4 Magnetic Fields
4 Plumbagin
4 Resveratrol
3 5-fluorouracil
3 Berbamine
3 Boswellia (frankincense)
3 α-Bisabolol / Chamomile oil
3 Carnosic acid
3 Chlorogenic acid
3 Dandelion Root
3 Evodiamine
3 Ferulic acid
3 Gallic acid
3 Geraniol
3 Gossypol/AT-101
3 HydroxyTyrosol
3 Hyperoside
3 Isoliquiritigenin
3 isoorientin
3 Vitexin
3 Licorice
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Propolis -bee glue
3 Piperlongumine
3 Selenium NanoParticles
3 Aflavin-3,3′-digallate
2 Astragalus
2 Andrographis
2 Anethole/trans-Anethole
2 Aloe anthraquinones
2 Beta-Caryophyllene
2 Brucea javanica
2 Bullatacin
2 Thymol-Thymus vulgaris
2 Celastrol
2 Centella asiatica / Gotu kola → asiaticoside
2 Cichoric acid / Chicoric acid
2 Carvone
2 Polyphenols
2 Deguelin
2 Docetaxel
2 Echinacea
2 Electrical Pulses
2 Paclitaxel/Taxol
2 Hydrogen Gas
2 Chemotherapy
2 Hibiscus sabdariffa
2 Rutin
2 Isobavachalcone
2 phytic acid, Inositol hexakisphosphate
2 Isorhamnetin
2 isoquercitrin
2 lambertianic acid
2 low dose naltrexone
2 Linalool
2 methylseleninic acid
2 Mangiferin
2 doxorubicin
2 Mistletoe/Viscum album Extracts
2 Nimbolide
2 Oleuropein
2 Phycocyanin
2 Rosmarinic acid
2 salinomycin
2 Selenium
2 chitosan
2 Selenite (Sodium)
2 Ursolic acid
1 1,8-Cineole
1 entinostat
1 Camptothecin
1 Resiquimod
1 Gemcitabine (Gemzar)
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Fennel Oil/Foeniculum vulgare
1 Metformin
1 2-DeoxyGlucose
1 almonertinib
1 epirubicin
1 Biochanin A
1 Bufalin/Huachansu
1 brusatol
1 borneol
1 Caffeic acid
1 Sorafenib (brand name Nexavar)
1 Celecoxib
1 Chlorophyllin
1 Cinnamon
1 immunotherapy
1 Crocetin
1 Cucurbitacin
1 Cynaropicrin
1 Diclofenac
1 diet Methionine-Restricted Diet
1 Ellagic acid
1 Ginkgo biloba-EGb 761
1 Geldanamycin
1 Radicicol/monorden
1 Flaxseed/Linseed
1 olaparib/LYNPARZA
1 Ginkgolic acids
1 Ginkgo biloba
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Hydroxycinnamic-acid
1 Helleborus niger extracts – Christmas Rose
1 Baicalin
1 Indole-3-carbinol
1 carboplatin
1 Isovitexin
1 L-Theanine
1 Lactobacillus
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 Magnetic Field Rotating
1 Moringin
1 Melatonin
1 Moringa oleifera
1 Methylsulfonylmethane
1 Marjoram (Origanum majorana)
1 Patchouli Oil (Pogostemon cablin)
1 sericin
1 Propyl gallate
1 topotecan
1 Piperine
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Sanguinarine
1 α-Santalol/Sandalwood oil
1 polyethylene glycol
1 Auranofin
1 Spirulina(Arthrospira/Limnospira)
1 Terpinen-4-ol / Tea Tree Oil
1 Urolithin
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
1 Vitamin K2
1 VitK3,menadione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:45  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page